Summary Although EGF receptor expression is generally elevated in human lung squamous carcinoma, the biological significance of this phenomenon and the role of EGF and TGF-a in this disease are poorly understood. We have investigated three human lung squamous carcinoma cell lines (NX002, CX140 and CX143) and have shown, using an antibody (EGFRI) directed against the EGF receptor, that the majority of cells in all three lines express the EGF receptor. Using a ligand binding assay, Scatchard analysis indicated high concentrations (1,300-2,700 fmol mg-' protein) of a single low affinity binding site (Kd = 3-5 nM) within these lines. Addition of EGF or TGF-a at concentrations greater than 0.1 nm resulted in growth inhibition of all three lines and this was associated with an accumulation of cells in the G2/M phase of the cell cycle. Growth inhibitory effects were not explained by an enhancement of cellular differentiation as monitored by involucrin expression and the ability to form cornified envelopes. While the presence of EGF could not be detected in medium conditioned by the NX002 cell line, mRNA for TGF-a was detected in all three lines suggesting the possibility of an autocrine loop. These results together with reports of growth inhibition by EGF and TGF-a in other systems suggest that EGF and similar molecules might have a growth regulatory role in lung cancer cells and modulation of such may have therapeutic potential.
The related molecules, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-ax), modulate the growth of a wide variety of normal and malignant cells (reviewed in Burgess et al., 1989) . Both factors operate through the EGF receptor and in many malignant diseases, for example lung squamous carcinoma, levels of the EGF receptor are markedly overexpressed relative to normal tissue (Hendler & Ozanne, 1984; Cerny et al., 1986; Berger et al., 1987; Veale et al., 1987; Sobol et al., 1987; Dazzi et al., 1989) . The biological significance of this overexpression of receptors in lung squamous carcinoma is not known. Cell lines derived from human lung squamous carcinoma cell lines have been shown to possess high concentrations of EGF receptors (Haeder et al., 1988) and represent useful models to study growth factor modulation. Little is known of the role of EGF and TGF-x in this disease, however, several reports have proposed that TGF-o may act in an autocrine manner in this cell type (Lee et al., 1990; Putnam et al., 1991) while another recent study has suggested that either EGF or TGFa might stimulate squamous differentiation (Levitt et al., 1991) .
In order to investigate further the role of EGF-like factors in lung squamous carcinoma cells, we have developed cell line models and have examined them for the presence of EGF receptors. Two approaches have been used to detect and measure the levels of this receptor: immunocytochemical staining using an antibody directed against the receptor and a competitive binding assay employing radiolabelled EGF. We have also studied the effects of EGF and TGF-oc on the growth characteristics of these lines by examining changes in cell number and in the cell cycle distribution after exposure to these agents. The possibility that these factors induce differentiation within these cells was examined and finally, we have looked for the expression of EGF protein and TGF-a mRNA as an indication that these factors might exert control via an autocrine pathway.
Materials and methods

Cell lines
The human lung squamous carcinoma cell lines NX002, CX140 and CX143 were established and characterised as previously described (Rabiasz et al., 1991) . They were maintained routinely at 37TC in a humidified atmosphere of 5% CO2 in air in RPMI 1640 (Gibco) containing 5% heatinactivated foetal calf serum (FCS) and supplemented with Streptomycin (100 jig ml-'), Penicillin (100 IU ml-') and glutamine (2 mM).
Immunocytochemical detection of EGF receptor and involucrin The presence of EGF receptors and involucrin were detected using an immunoperoxidase method employing avidin-biotinylated horseradish peroxidase complex. The murine monoclonal antibody EGFR1, which was raised against the A431 cell line (Waterfield et al., 1982) Slides were thawed and incubated for 10 min at room temperature with 3% hydrogen peroxide to block endogenous peroxide activity. The slides were then washed in 0.05 M Tris Buffer (TB), pH 7.6 and incubated with rabbit serum (Dako) in TB (1:5) for 20 min followed by incubation with the mouse monoclonal antibody (EGFR1 1:100) for 30 min. A further wash in TB was followed by incubation for 30 min with biotinylated rabbit anti-mouse immunoglobulin (Dako) diluted in TB (1:200). After washing, AB complex was applied to cells and left for 30 min. A final TB wash was given before peroxidase was localised using a fresh 1 mg ml-' mixture of 3,3 diaminobenzidine tetrahydrochloride (DAB) and 0.01% hydrogen peroxide in Tris imidazole buffer, pH 7.6 for 10 min. After washing with water, cells were counterstained with hematoxylin and scored for the presence and intensity of positive staining by 2 or 3 independent readers. The vulval carcinoma cell line, A43 1, which is known to overexpress EGF receptors (Haigler et al., 1978) was used as a positive control and the small cell lung cancer cell line, H69, known to lack EGF receptors (Gamou et al., 1987) 0.02 nM = 10,000 c.p.m.) to give a final reaction volume of 400 gl for 90 min at 26°C. The reaction was terminated by the addition of ice-cold 0.5% (w/v) IgG, followed by mixing and addition of 25% (w/v) polyethylene glycol. After further mixing, the bound and free '25I-EGF were separated by centrifugation. The supernatant containing the free component was aspirated, and the remaining pellet counted in a Packard Multi-Prias Gamma Counter. The data was analysed by the method of Scatchard (1949) . The plots were then examined by the computer analysis method of Hetherington to assign, fit and calculate both the slopes and intercepts of the components (Nicholson et al., 1989; Sainsbury et al., 1985) .
Effect of EGF and TGF-a on the growth of the cell lines Exponentially growing cells were harvested by trypsinisation and plated in 24-well plates (Falcon) at densities of approximately 2 x 104 cells/well (four wells per experimental condition) in RPMI 1640 (Gibco) containing 5% FCS. After 48 h, medium was removed and cells were washed with PBS. Human recombinant EGF (hEGF; ICN) or TGF-x (Boerhinger) were added at concentrations ranging from 0.001 nM to 10 nM in RPMI 1640 containing 5% FCS. This time point was designated day 0. Media containing EGF or TGF-a was replenished on days 2 and 5. On days 0, 2, 5 and 7, cells were harvested and counted using a Coulter Counter.
To examine growth in serum-free conditions, cells were plated into 24-well plates as described above and medium changed after 24 h to RPMI 1640 with hydrocortisone (10 nM), insulin (5 jg ml-), transferrin (10 tg ml-') and sodium selenite (30 nM). After a further 24 h, growth factors were added in the same medium and the experiment conducted as described above for serum containing medium.
Cornified envelope competence assay
The competence of cells to form cornified envelopes was determined essentially according to the method described by Rice and Green (1979) . Semi-confluent cultures were treated for 4 days with either TPA (10 nM) or EGF (10 nM) Figure 2 Effects of EGF and TGF-o on the growth of the cell lines. Cells were exposed to factors for 7 days with media being replenished on days 2 and 5. Cell numbers relative to those in control cultures (without growth factor) are shown and represent the mean ± standard deviation of four values. For the experiments shown, the change in cell number between Day 0 and Day 7 for the untreated groups were as follows: 7.7-fold for NX002; 8.4-fold for CX140 and 9.1-fold for CX143.
(Kd = 0.2 nM), a result consistent with previous reports (Kawamoto et al., 1983) . The effect of a 7-day exposure of EGF and TGF-a on the growth of the lung cell lines is shown in Figure 2 . Both EGF and TGF-a inhibited growth of the cell lines in a dosedependent fashion at concentrations greater than 0.1 nM. The level of inhibition is similar between the cell lines and both EGF and TGF-oa produced equivalent effects. Cell counts were also performed after 2 and 5 days exposure to the factors and inhibition was also seen at these time points (data not shown). EGF was equally effective in serum-free as in serum-containing medium (Figure 3) .
The influence of EGF and TGF-ca on the cell cycle distribution of the cell lines was studied. After a 48 h exposure to either EGF or TGF-a at 1 or 10 nM, cells in all three lines began accumulating in the G2,/M phase of the cell cycle with a consequent reduction in the percentage of cells in GO GI (Figure 4 ). Both concentrations of factor produced similar effects. Similar changes were observed at 72 h (data not shown).
EGF (10 nM) produced changes in the appearance of NX002 cells with increased spreading on the plastic substrate ( Figure 5 ). Multinucleation could be seen in many cells consistent with cells accumulating at the G2 M phase ( Figure 5 ). The possibility that growth inhibition by EGF was related to an enhancement in differentiation was examined by investigating the percentage of cells expressing the differentiation marker involucrin and the percentage of cells competent to form cornified envelopes after exposure to 10 nM EGF. Under conditions in which a known inducer (12-O-tetradecanoylphorbol acetate) increased the percentage of cells expressing involucrin or competent to form cornified envelopes. EGF did not produce a significant change (Figure 6 ).
Since the cell lines express EGF receptors and respond to addition of exogenous factors, it is feasible that the factors might operate in an autocrine fashion within these cell lines. Using an RNAse protection assay, the expression of an mRNA transcript was detected within these lines at approximately 1,050 base pairs consistent with the length of template DNA used to synthesise the complementary probe for TGF-a (Figure 7) . By radioimmunoassay, EGF could not be detected within medium conditioned by the NX002 cell line (limit of detection = 0.2 ng ml-').
Discussion
The lung squamous carcinoma cell lines described in this report contain high concentrations of EGF receptors as demonstrated by a ligand binding assay. These values of 1,300-2,700 fmol mg-' protein are higher but comparable to the values previously reported by Haeder et al. (1988) Concentration (nM) Figure 3 Effect of EGF on the growth of the NX002 cell line in serum-containing and serum-free conditions. Cells were exposed to EGF at the concentrations shown for 7 days with media and factor being replenished on days 2 and 5. Cell numbers relative to those in control cultures (without added EGF) are shown and represent the mean + standard deviation of four values. For the experiments shown the change in cell number between Day 0 and Day 7 for the untreated groups were 8.6-fold for the 5% serumcontaining group and 10.5-fold for the serum free group.
Kd values from 1-3 nM. Only a single low affinity binding population (Kd = 3 -5 nM) could be deduced from the straight line plots obtained for our lung lines while two populations of receptor could be identified from the biphasic curve obtained in the Scatchard analysis for the A431 cell line.
Addition of nanomolar concentrations of EGF or TGF-a inhibited growth of the three lung carcinoma cell lines. This is consistent with data from squamous cell lines of other histologies, such as A431 cells, where EGF, when added at nanomolar concentrations, is inhibitory to systems showing very high concentrations of the EGF receptor although, if added at picomolar concentrations, EGF can be stimulatory (Gill & Lazar, 1981; Barnes, 1982; Filmus et a!., 1985; Kamata et al., 1986 ). In several studies the level of inhibition has been shown to increase as the EGF receptor number increases (Kamata et al., 1986; .
Detailed studies of the A431 cell line, employing clonal xariants and using antibodies with different specificities for the high and low affinity EGF binding sites, have suggested that the low affinity receptor in A431 cells (which accounts for > 99%0 EGF binding at nM concentrations) is responsible for growth inhibition while the high affinity site (accounting for about 0.1% binding) is associated with growth stimula- tion at pM levels of EGF or TGF-x (Kawamoto et al., 1983 Gill et al., 1984) . Therefore the absence of high affinity binding sites in the lung carcinoma lines might explain a lack of stimulation at picomolar concentration of factors. After exposure of these cell lines to EGF or TGF-x, cells accumulated in the G2/M phase of the cell cycle. This is consistent with the blockade of A431 cells in the G2 phase of the cell cycle as reported by MacLeod et al. (1986) inhibition of these lines by EGF was related to enhanced differentiation was investigated but there was no increase in the percentage of cells expressing the differentiation-related marker involucrin or in the ability to produce cornified envelopes. EGF has been shown to have a variety of effects on squamous carcinoma systems including both promotion (Levitt et al., 1991) and inhibition of differentiation (Reiss & Sartorelli, 1987) while others have shown no effect (Ponec et al., 1988) . Although the secretion of EGF by these cell lines could not be detected by radioimmunoassay, the presence of TGFa mRNA could be demonstrated. TGF-o mRNA and TGF-a protein have been identified in at least 2 other lung squamous carcinoma cell lines (Soderdahl et al., 1988; Lee et al., 1990) while experiments using blocking antibodies to TGF-a have resulted in growth modulation of this cell type (Levitt et al., 1991) .
In conclusion, these results indicate that both EGF and TGF-a are growth inhibitory to lung squamous carcinoma cells expressing high levels of low-affinity binding receptors. Since TGF-a is also expressed by these cell lines, these data lends support to the hypothesis that this factor may play an autocrine role in this disease and modulation of such may have therapeutic potential. 
